+ Product Pathways
- All Targets
- Angiogenesis/Tyrosine Kinase
- Cell Cycle/Checkpoint
- HDAC
- Apoptosis
- PARP
- Aurora/Ksp
- MAPK
- PI3K/Akt/mTOR
- Hormone
- Integrase/CCR5
- Proteases/HSP90/HSP70
- Wnt/Hedgehog/Notch
- Jak/Stat
- Ca/cAMP/Lipid Signaling
- Neuro Signaling
- TGF-beta/Smad Signaling
- GPCR
- Ion channel
- Cytochrome P450
- Others
- Cancer
- Infection
- Endocrinology
- Metabolic Disease
- Inflammation
- Immunology
- Neurological Disease
- Cardiovascular Disease
Histone deacetylases
| Cat.No. | Product Name | Feedback | Added |
|---|---|---|---|
| S2244 | AR-42 (HDAC-42) | Jun 2011 | |
| AR-42 is a novel HDAC inhibitor with an IC50 of 0.61 μM for acute lymphoblastic leukemia (697) cell lines. | |||
| S1085 | Belinostat (PXD101) | Jul 2009 | |
| Belinostat also known as PXD101 is a HDAC inhibitor with IC50 of 27 nM. | |||
| S1194 | CUDC-101 | May 2010 | |
| CUDC-101 is a potent multitargeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively. | |||
| S1422 | Droxinostat | Jul 2010 | |
| Droxinostat is a selective inhibitor of HDAC3, HDAC6, and HDAC8 (IC50 at 16.9 ,2.47 and 1.46 μM, respectively). | |||
| S2170 | ITF2357 (Givinostat) | Jan 2011 | |
| ITF2357 (Givinostat) is a noverl HDAC inhibitor with IC50 of 10, 7.5 and 16 nM for maize HDAC preparations HD2, HD-1B and HD-1A, respectively. | |||
| S1096 | JNJ-26481585 | Aug 2009 | |
| JNJ-26481585 is an orally bioavailable, second-generation, hydroxamic acid-based HDAC inhibitor with an IC50 of 2.43 nM for 5T33MMvt cells. | |||
| S1095 | LAQ824 (NVP-LAQ824) | Aug 2009 | |
| LAQ824 (NVP-LAQ824) is an HDAC inhibitor with an IC50 of 0.032 μM. | |||
| S1030 | LBH589 (Panobinostat) | Apr 2009 | |
| LBH589 (Panobinostat) is a HDAC inhibitor, IC50 for inhibition of proliferation in MOLT-4 cells is approximately 5 μM and for Reh cells is approximately 20 μM. | |||
| S1484 | MC1568 | Sep 2010 | |
| MC1568 is a potent selective class II (IIa) histone deacetylas (HDAC II) inhibitor (IC50 of a maize deacetylase HD2 at 22.0 µM). | |||
| S1122 | MGCD0103 (Mocetinostat) | Oct 2009 | |
| MGCD0103 (Mocetinostat) is a potent HDAC inhibitor with IC50 of 0.15, 0.29 and 1.66 μM for HDAC 1, HDAC 2 and HDAC 3, respectively. | |||
| S1053 | MS-275 (Entinostat) | Apr 2009 | |
| MS-275 (Entinostat) is a potent HDAC inhibitor with IC50 of 0.3 and 8µM for HDAC1 and HDAC3, respectively. | |||
| S1090 | PCI-24781 | Jul 2009 | |
| PCI-24781 (CRA-024781) is an HDAC inhibitor with Ki of 7 μM. | |||
| S1515 | SB939 | Sep 2010 | |
| SB939 is a novel potent and orally active histone deacetylase inhibitor with an IC50 of 52 nM for HDAC1 and a GI50 of 0.56 µM for Colo205. | |||
| S1045 | Trichostatin A (TSA) | Apr 2009 | |
| Inhibitor of HDAC, HDAC inhibitory activity of TSA was similar in all cell lines with mean ± SD IC50 of 2.4 ± 0.5 nm (range, 1.5–2.9 nm) | |||
| S2627 | Tubastatin A hydrochloride | Aug 2011 | |
| Tubastatin A hydrochloride is a potent selective HDAC6 inhibitor with an IC50 of 15 nM. | |||
| S1168 | Valproate | Mar 2010 | |
| Valproate is a histone deacetylase inhibitor with an IC50 of 0.4 mM and exhibits anticancer, anti-inflammatory and neuroprotective effects. | |||
| S1047 | Vorinostat (SAHA) | Apr 2009 | |
| Vorinostat also known as SAHA, Zolinza, MK-0683 is an HDAC inhibitor. Vorinostat CAS No 149647-78-9 with purity >99% & solubility DMSO is available. | |||
Buy Now / Print Quote
Find Multiple Products by Catalog Number
Customer's Feedback
| Dongfeng Chen, The Rausing Lab |
| "Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future." |
| R.B. Cambridge |
| "I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more." |
| Zhenghe John Wang Assistant Professor, Case Western Reserve University |
| "We have purchased LBH-589, Saha and MS-275 from you and they all worked well." |
| Jenny Sun |
| "We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility." |
| Yu Wang, Harvard University |
| "The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research." |
| Dung-Fang Lee |
| "Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells." |
Latest Catalog
| May 2010 Selleck Latest Catalog | ![]() |

